DR. Brandon Shin-nin Lu, M.D., M.S. is a sleep medicine internal medicine in San Francisco, CA with 25 years of experience. The provider is an Internist who practices Sleep Medicine is certified in the subspecialty of sleep medicine and specializes in the clinical assessment, physiologic testing, diagnosis, management and prevention of sleep and circadian rhythm disorders. Sleep specialists treat patients of any age and use multidisciplinary approaches. Disorders managed by sleep specialists include, but are not limited to, sleep related breathing disorders, insomnia, hypersomnias, circadian rhythm sleep disorders, parasomnias and sleep related movement disorders. DR. Brandon Shin-nin Lu, M.D., M.S. NPI is 1093836710. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Graduation Year:1999
The provider's business location address is:
1100 VAN NESS AVE STE 1005
SAN FRANCISCO, CA
ZIP 94109-980
Phone: (415) 923-3421
Fax: (415) 243-8666
The NPI 1093836710 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Measurement of lung diffusing capacity (HCPCS:94729)
- Determination of lung volumes using plethysmography (HCPCS:94726)
- Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration (HCPCS:94060)
- Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort (HCPCS:95806)
The enumeration date for this NPI number is 4/2/2007 and was last updated on 2/8/2021.